Stephanie Morley serves as Executive at Zomedica Pharmaceuticals Corp., where they oversee executive responsibilities. Since joining the company, Stephanie Morley has executed 7 insider transactions totaling $933.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 12, 2021 involved selling 305,000 shares valued at $353.8K.
Stephanie Morley currently holds 1,459,580 shares of Zomedica Pharmaceuticals Corp. (ZOM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephanie Morley has been a net seller of ZOM stock. They have purchased $0 and sold $933.8K worth of shares.
Stephanie Morley's most recent insider trade was on Apr 12, 2021, when they sold 305,000 shares at $1.16 per share.
Get notified when new Form 4 filings are submitted
| $0.19 |
| Discretionary |
| Apr 12, 2021 | ZOM | $215.0K | Option Exercise | 500,000 | $0.43 | Discretionary |
| Apr 12, 2021 | ZOM | $580.0K | Sale | 500,000 | $1.16 | Discretionary |
| Apr 20, 2018 | ZOM | $20.8K | Option Exercise | 104,000 | $0.20 | Discretionary |
| Mar 29, 2018 | ZOM | $1.1M | Option Exercise | 500,000 | $2.20 | Discretionary |
| Mar 29, 2018 | ZOM | $100.0K | Option Exercise | 500,000 | $0.20 | Discretionary |